Literature DB >> 23584340

Implications of the FDA draft guidance on biosimilars for clinicians: what we know and don't know.

Edward Li1, James M Hoffman.   

Abstract

Mesh:

Substances:

Year:  2013        PMID: 23584340     DOI: 10.6004/jnccn.2013.0052

Source DB:  PubMed          Journal:  J Natl Compr Canc Netw        ISSN: 1540-1405            Impact factor:   11.908


× No keyword cloud information.
  2 in total

1.  Biosimilars: Implications for health-system pharmacists.

Authors:  Steven D Lucio; James G Stevenson; James M Hoffman
Journal:  Am J Health Syst Pharm       Date:  2013-11-15       Impact factor: 2.637

2.  Biosimilar medicines uptake: The role of the clinical pharmacist.

Authors:  Roland Nnaemeka Okoro
Journal:  Explor Res Clin Soc Pharm       Date:  2021-04-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.